This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in tre…

Open Wound

~Estimated

~$10 – $8,750

NuScience Medical Biologics, LLCNCT06918561

Phase 1

Protocol ELU42 01 01: Phase I/IIA, Open Label, Single Arm Evaluation of Topical ELU42 (XAV939 in DHA77) for Wagner Grade 1-2 Diabetic Foot Ulcers

ELU42 01 01 (SuperHealer42) is a Phase I/IIA open label study sponsored by Eluciderm, Inc. that evaluates the safety and preliminary effectiveness of ELU42, a …

Diabetic Foot UlcerWagner Grade 1 - 2Chronic Wound+1 more

~Estimated

~$10 – $8,750

Eluciderm IncNCT07396376

Phase 1

Micro/Nanobubbles (MNBs) and Wound Therapy: A Pilot Study Involving a Novel Oxygen Delivery System for Treatment of Acute and Chronic Wounds

The purpose of this study is to assess the safety and efficacy of Micro/nanobubbles (MNB's) for the healing of acute and chronic wounds.

Open WoundWound Heal

~Estimated

~$10 – $6,250

University of California, IrvineNCT05169814